Current Net Margin
-5.52%
Tarsus Pharmaceuticals, Inc. currently has a net profit margin of -5.52%.
Financial Fundamentals
TARS • Quarterly Data • 5Y View
Historical Margin Data
| Date | Rev ($B) | NI ($B) | Net Margin | Change (bps) |
|---|---|---|---|---|
| 2025-12-31 | 0.15 | -0.01 | -5.52% | ▲508 |
| 2025-09-30 | 0.12 | -0.01 | -10.60% | ▲921 |
| 2025-06-30 | 0.10 | -0.02 | -19.81% | ▲1225 |
| 2025-03-31 | 0.08 | -0.03 | -32.07% | ▲274 |
| 2024-12-31 | 0.07 | -0.02 | -34.80% | ▲1387 |
| 2024-09-30 | 0.05 | -0.02 | -48.67% | ▲3290 |
| 2024-06-30 | 0.04 | -0.03 | -81.57% | ▲4783 |
| 2024-03-31 | 0.03 | -0.04 | -129.39% | ▲19106 |
| 2023-12-31 | 0.01 | -0.04 | -320.45% | ▲177191 |
| 2023-09-30 | 0.00 | -0.04 | -2092.36% | — |
| 2023-06-30 | 0.00 | -0.03 | — | — |
| 2023-03-31 | 0.00 | -0.02 | -936.76% | ▼80077 |
| 2022-12-31 | 0.01 | -0.01 | -135.99% | — |
| 2022-09-30 | 0.00 | -0.02 | — | — |
| 2022-06-30 | 0.02 | -0.01 | -37.59% | ▲371714 |
| 2022-03-31 | 0.00 | -0.02 | -3754.73% | ▲63906 |
| 2021-12-31 | 0.00 | -0.01 | -4393.79% | ▼312790 |
| 2021-09-30 | 0.00 | -0.02 | -1265.89% | ▼129450 |
| 2021-06-30 | 0.02 | 0.01 | 28.61% | ▼216 |
| 2021-03-31 | 0.03 | 0.01 | 30.77% | — |
| 2020-12-31 | 0.00 | -0.01 | — | — |
| 2020-09-30 | 0.00 | -0.01 | — | — |
| 2020-06-30 | 0.00 | -0.00 | — | — |
| 2020-03-31 | 0.00 | -0.00 | — | — |
| 2019-12-31 | 0.00 | -0.00 | — | — |
| 2019-09-30 | 0.00 | -0.00 | — | — |
| 2018-06-30 | 0.00 | -0.00 | — | — |
| 2018-03-31 | 0.00 | -0.00 | — | — |
* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.